
Sign up to save your podcasts
Or


Ingmar Gorman, Ph.D. clinical psychologist and principal investigator in MAPS’ research into MDMA-assisted psychotherapy, is our guest this week. Ingmar shares with us his journey into the world of psychedelic therapy, and what he hopes the research at MAPS can achieve. We also discuss the rise of microdosing, and why Ingmar believes we should be cautious about its benefits.
For show links: https://thethirdwave.co/podcast/episode-47-ingmar-gorman/
Sign up to our microdosing course! https://thethirdwave.co/microdosing-course/
By Third Wave4.7
306306 ratings
Ingmar Gorman, Ph.D. clinical psychologist and principal investigator in MAPS’ research into MDMA-assisted psychotherapy, is our guest this week. Ingmar shares with us his journey into the world of psychedelic therapy, and what he hopes the research at MAPS can achieve. We also discuss the rise of microdosing, and why Ingmar believes we should be cautious about its benefits.
For show links: https://thethirdwave.co/podcast/episode-47-ingmar-gorman/
Sign up to our microdosing course! https://thethirdwave.co/microdosing-course/

2,555 Listeners

10,522 Listeners

3,994 Listeners

11,865 Listeners

1,876 Listeners

2,633 Listeners

1,289 Listeners

12,754 Listeners

1,925 Listeners

556 Listeners

1,665 Listeners

1,050 Listeners

184 Listeners

630 Listeners

227 Listeners